moxifloxacin has been researched along with trypan blue in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (trypan blue) | Trials (trypan blue) | Recent Studies (post-2010) (trypan blue) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 9 | 0 | 4 |
| 3,157 | 552 | 1,690 | 2,857 | 40 | 414 |
| Protein | Taxonomy | moxifloxacin (IC50) | trypan blue (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.9 | |
| Tyrosine-protein phosphatase 1 | Saccharomyces cerevisiae S288C | 7.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dahl, P; Hu, DN; Koplin, RS; McCormick, S; Meskin, SW; Ritterband, DC; Seedor, JA; Shah, MK; Shao, S; Shapiro, DE | 1 |
2 other study(ies) available for moxifloxacin and trypan blue
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.
Topics: Anthraquinones; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Coloring Agents; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Humans; Middle Aged; Moxifloxacin; Organ Preservation; Organ Preservation Solutions; Quinolines; Tissue Donors; Trypan Blue | 2006 |